The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,001–17,100 of 31,469
Bilson, J., Oquendo, C. J., Read, J., Scorletti, E., Afolabi, P. R., Lord, J., Bindels, L. B., Targher, G., Mahajan, S., Baralle, D., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155759 · Cited by 21
Pettersson-Pablo, P., Nilsson, T. K., & Hurtig‐Wennlöf, A. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111057 · Cited by 16
Dessel, K. V., Verrijken, A., Block, C. E. M. D., Verhaegen, A. A., PEIFFER, F. W., Gaal, L. V., Wachter, C. D., & Dirinck, E. L. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.12.024 · Cited by 16
Size and dose of nanoparticles modulate between toxic and medicinal effect on kidney
Nolte, T. M., & Lu, B. (2024) · OpenNano · doi:10.1016/j.onano.2024.100200 · Cited by 17
Chia, A., Toh, J. Y., Padmapriya, N., et al. (2024) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-024-01564-z · Cited by 16
Hassan, N. E., El-Masry, S. A., Shebini, S. M. E., Ahmed, N. H., Fouad, M. T., Mostafa, M. I., Afify, M. A. S., Kamal, A. N., Badie, M. M., Hashish, A. F., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54285-5 · Cited by 20
Duft, R. G., Bonfante, I. L. P., Palma-Duran, S. A., Chacon‐Mikahil, M. P. T., Griffin, J. L., & Cavaglieri, C. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae177 · Cited by 18
Wang, Z., van Faassen, M. H. J. R., Groen, H., Cantineau, A. E., van Oers, A. M., van der Veen, A., Hawley, J. M., Keevil, B. G., Kema, I. P., & Hoek, A. (2024) · Human Reproduction · doi:10.1093/humrep/deae058 · Cited by 16
Gut bacteriome and mood disorders in women with PCOS
Lee, S., Tejesvi, M. V., Hurskainen, E., Aasmets, O., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., Ruuska, T. S., Altmäe, S., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae073 · Cited by 16
Associations of Childhood Adiposity and Cardiometabolic Biomarkers With Adolescent PCOS
Whooten, R., Rifas‐Shiman, S. L., Perng, W., Chavarro, J. E., Taveras, E. M., Oken, E., & Hivert, M. (2024) · PEDIATRICS · doi:10.1542/peds.2023-064894 · Cited by 16
Martínez‐Montoro, J. I., Martínez‐Sánchez, M. A., Román, A. B., et al. (2024) · Nutrients · doi:10.3390/nu16091310 · Cited by 16
Lin, Y., Zhang, Z., Zhong, J.-Q., Wang, Z., Peng, Y.-T., Lin, Y.-M., Zhang, H.-P., & Tian, J.-Q. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302155 · Cited by 17
Retnakaran, R. R., Pu, J., Ye, C., et al. (2024) · Diabetes Care · doi:10.2337/dc24-1375 · Cited by 16
Association between cardiometabolic index and gestational diabetes mellitus: a cross-sectional study
Chen, M., Xiong, S., Zheng, J., Zhang, J., Ye, D., Xian, Y., Cao, Q., & Yan, K. (2024) · Endocrine · doi:10.1007/s12020-024-04045-2 · Cited by 19
Ananda, R. A., Gwini, S. M., Beilin, L. J., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.070039 · Cited by 16
Cai, H., Que, Z., Chen, J., Chen, D., Rui, G., & Lan, W. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-08027-3 · Cited by 17
Ruano, G. R., Nogueira, G. A. S., Dadson, P., Ferreira, S. R. G., Sapienza, M. T., Velloso, L. A., & Monfort‐Pires, M. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.103801 · Cited by 20
Shirinezhad, A., Azarboo, A., Raeini, A. G., Nejad, F. K., Zareshahi, N., Amiri, S. M., Tahmasebi, Y., & Hoveidaei, A. H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1499479 · Cited by 17
Saber, S., & Mirgani, S. M. (2025) · Advances in Complex Systems · doi:10.1142/s1793962325500308 · Cited by 16
Engel, Helfrich, Manderscheid, Musholt, Forst, Pfützner, & Dahmen (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s18455 · Cited by 16
Serum transaminases concentrations in obese children and adolescents
González‐Gil, E. M., Bueno, G., Lozano, O. B., et al. (2009) · Journal of Physiology and Biochemistry · doi:10.1007/bf03165969 · Cited by 16
Vinitha, R., Jagannathan, R., Snehalatha, C., Nanditha, A., Shetty, A. S., Raghavan, A., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.035 · Cited by 16
Zethelius, B., & Cederholm, J. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.09.003 · Cited by 17
The association between apolipoprotein M and insulin resistance varies with country of birth
Memon, A. A., Bennet, L., Zöller, B., Wang, X., Palmér, K., Dahlbäck, B., Sundquist, J., & Sundquist, K. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.007 · Cited by 16
Fontbonne, A., Cournil, A., Cames, C., Mercier, S., Coly, A. N., Lacroux, A., Dupuy, A., Diop, S. N., Cristol, J., & Bork, K. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.008 · Cited by 16
Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents
Zaki, M. E., & Amr, K. S. (2013) · Gene · doi:10.1016/j.gene.2013.10.032 · Cited by 16
Magkos, F., Patterson, B. W., Mohammed, B. S., & Mittendorfer, B. (2008) · Clinical Science · doi:10.1042/cs20080220 · Cited by 15
Session 4: CVD, diabetes and cancer Diet, insulin resistance and diabetes: the right (pro)portions
Spence, M., McKinley, M. C., & Hunter, S. J. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109991789 · Cited by 15
Dietary sucrose intake is related to serum leptin concentration in overweight pregnant women
Vähämiko, S., Isolauri, E., Pesonen, U., Koskinen, P. J., Ekblad, U., & Laitinen, K. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0052-8 · Cited by 16
Adiponectin and Its Receptors in Chronic Hepatitis B Patients With Steatosis in China
Wu, D., Li, H., Xiang, G., Zhang, L., Li, L., Cao, Y., & Zhang, J. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.6065 · Cited by 17
Intrahepatic lipid content is linked to insulin resistance in obese subjects
Sada, Y., Katabami, T., Asai, S., Sato, T., Furukawa, K., Ishii, S., Kato, H., KOBAYASHI, H., Kondo, A., Ohta, A., et al. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2010.12.007 · Cited by 16
Jiang, Y., Chuang, L., Pei, D., Lee, Y., Wei, J.-N., Sung, F., & Chang, T. (2014) · International Journal of Endocrinology · doi:10.1155/2014/983016 · Cited by 16
Park, C. G., & Choi, K. M. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.863320 · Cited by 16
Wang, J., Lee, I., Lee, W., Lin, S., Fu, C., Ting, C.-T., Lee, W.-L., Liang, K., & Sheu, W. H. (2012) · Diabetes Care · doi:10.2337/dc12-1434 · Cited by 16
Panz, V. R., Immelman, A., Paiker, J. E., Pilcher, G. J., & Raal, F. J. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0063 · Cited by 16
Correlation between omental TNF-α protein and plasma PAI-1 in obesity subjects
Cao, Y. L., Wang, Y. X., Wang, D. F., Meng, X., & Zhang, J. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.05.033 · Cited by 16
Combined Nutraceutical Approach to Postmenopausal Syndrome and Vascular Remodeling Biomarkers
Cicero, A. F. G., Tartagni, E., Ferroni, A., et al. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0624 · Cited by 16
Shuumarjav, U., Kotani, K., Taniguchi, N., Yoshioka, H., Kario, K., Ishibashi, S., Yamada, T., Kawano, M., Nyamdavaa, K., Itoh, K., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.1354 · Cited by 16
Chen, C.-H., Lin, T., Chen, T.-T., Chen, V. C., Lin, N.-C., Shao, W., & Lu, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.01.015 · Cited by 16
O'Sullivan, E. P., Ashley, D. T., Davenport, C., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.06.005 · Cited by 16
Hage, C., Malmberg, K., Rydén, L., & Wallander, M. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.09.469 · Cited by 16
Rapid emergence of multimarker strategies in laboratory medicine
Gruson, D., & Bodovitz, S. (2010) · Biomarkers · doi:10.3109/13547500903560065 · Cited by 16
Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., & Iwasaka, T. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-327 · Cited by 16
Chen, Y., Lai, M.-H., Hsin-Yu, H. U. N. G., & Liu, J. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.272 · Cited by 16
Derbent, A., Kargılı, A., Koca, C., Gümüş, İ. İ., Sevgili, S., Simavlı, S. A., Karakurt, F., & Turhan, N. Ö. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487612 · Cited by 16
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., & Conde, R. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000209268 · Cited by 16
Mantovani, R. M., Rios, D. R. A., de Moura, L. R., de Oliveira, J. M. G., Carvalho, F. F., da CUNHA, S. B., Viana, M. F., Lamounier, J. A., Castro, J. C., Dusse, L. M. S., et al. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.015 · Cited by 16
Adami, G., Parodi, R. C., Papadia, F. S., Marinari, G. M., Camerini, G. B., Corvisieri, R., & Scopinaro, N. (2005) · Obesity Surgery · doi:10.1381/096089205774512483 · Cited by 16
Mirzaei, K., Hossein‐Nezhad, A., Emamgholipour, S., Ansar, H., Khosrofar, M., Tootee, A., & Alatab, S. (2012) · Lifestyle Genomics · doi:10.1159/000337352 · Cited by 16
Adams, S., Salhab, M., Hussain, Z., Miller, G., & Leveson, S. H. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0453-2 · Cited by 16
Megías, M. C., Albarrán, O. G., Guisado‐Vasco, P., et al. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.08.002 · Cited by 16
Carter, S., Li, Z., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Deshaies, Y., Després, J., & Picard, F. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.07.424 · Cited by 16
Influence of Abdominal Obesity on Vascular Endothelial Function in Overweight/Obese Adult Men
Weil, B. R., Stauffer, B. L., Mestek, M. L., & DeSouza, C. A. (2011) · Obesity · doi:10.1038/oby.2011.189 · Cited by 16
Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism
Ağbaht, K., Erdoğan, M. F., Emral, R., Başkal, N., & Güllü, S. (2013) · Endocrine · doi:10.1007/s12020-013-9951-9 · Cited by 16
Somma, C. D., Ciresi, A., Amato, M. C., Savastano, S., Savanelli, M. C., Scarano, E., Colao, A., & Giordano, C. S. D. S. (2014) · Endocrine · doi:10.1007/s12020-014-0471-z · Cited by 16
Kobayashi, Y., Kawaguchi, Y., Mizuta, T., Kuwashiro, T., Oeda, S., Oza, N., Takahashi, K., Iwane, S., Eguchi, Y., Anzai, K., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0338-x · Cited by 16
Lorenzo, C., Lee, R., & Haffner, S. M. (2012) · Diabetes Care · doi:10.2337/dc11-1902 · Cited by 16
Ono, Y., Kameda, H., & Cho, K. Y. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.770839 · Cited by 16
Yeung, C., Tso, A. W. K., Xu, A., Wang, Y., Woo, Y. C., Lam, T.-H., Lo, S., Fong, C. H. Y., Wat, N. M. S., Woo, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078594 · Cited by 16
Major depressive disorder and cardiometabolic disease risk among sub-Saharan African adults
Gelaye, B., Williams, M. A., Lemma, S., Berhane, Y., Fann, J. R., Stoep, A. V., & Zhou, X. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.05.003 · Cited by 16
Diabetes Mellitus Detection Based on Facial Block Texture Features Using the Gabor Filter
Shu, T., & Zhang, B. (2014) · IEEE International Conference on Computational Science and Engineering (CSE) · doi:10.1109/cse.2014.35 · Cited by 16
Salama, R. M., Schaalan, M. F., Elkoussi, A. A., & Khalifa, A. E. (2013) · BioMed Research International · doi:10.1155/2013/231378 · Cited by 16
Longo‐Mbenza, B., Mvindu, H. N., On'kin, J. B. K. L., Bikuku, N., Phanzu, B. K., Okwe, A. N., & Kabangu, N. K. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.05.001 · Cited by 16
High Prevalence of Cardio-Metabolic Risk Factors in a Young Urban Sri-Lankan Population
Wijesuriya, M., Gulliford, M. C., Charlton, J., Vasantharaja, L., Viberti, G. C., Gnudi, L., & Karalliedde, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031309 · Cited by 16
P-Wave Dispersion and Its Relationship to Aortic Elasticity in Young Prehypertensive Patients
Celık, T., Yüksel, U. Ç., Buğan, B., et al. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.157 · Cited by 16
Sáez, M. E., Smani, T., Ramírez‐Lorca, R., Díaz, I., Serrano‐Ríos, M., Ruiz, A., & Ordóñez, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019327 · Cited by 16
Lin, J., Chen, Y.-L., Hsu, C., Wu, C., Hsieh, A., Hsieh, C., Chang, J., Liang, Y.-J., & Pei, D. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.022 · Cited by 16
Zenibayashi, M., Miyake, K., Horikawa, Y., Hirota, Y., Teranishi, T., Kouyama, K., Sakaguchi, K., Takeda, J., & Kasuga, M. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-021 · Cited by 16
Pei, Y.-J., Wang, A., Zhao, Y., Yan, L., Li, M., White, R. E., & Han, G. C. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.829443 · Cited by 16
Gambino, R., Bo, S., Gentile, L., Musso, G., Pagano, G., Cavallo‐Perin, P., & Cassader, M. (2009) · Diabetes Care · doi:10.2337/dc09-1690 · Cited by 16
Euglycemic Clamp Insulin Sensitivity and Longitudinal Systolic Blood Pressure
Petrie, J. R., Malik, M. O., Balkau, B., Perry, C. G., Højlund, K., Pataky, Z., Nolan, J. J., Ferrannini, E., & Natali, A. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00439 · Cited by 17
Raissouni, N., Kolesnikov, A., Purushothaman, R., SINHA, S. K., Bhandari, S., Bhangoo, A., Malik, S., Mathew, R. P., Baillargeon, J., Hernández, M. I., et al. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-14 · Cited by 16
Hwang, Y., Ahn, H.-C., Yu, S. ‐., Park, S. ‐., & Park, C. ‐. (2013) · Diabetic Medicine · doi:10.1111/dme.12278 · Cited by 16
Finken, M. J. J., Meulenbelt, I., Dekker, F. W., Frölich, M., Walther, F. J., Romijn, J. A., Slagboom, P. E., Wit, J. M., & on behalf of the Dutch POPS-19 Collaborative Study Group (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0288 · Cited by 16
Khan, H. B. H., Vinayagam, K. S., Sekar, A., Shanthi, P., & Sachdanandam, P. (2011) · Journal of Dietary Supplements · doi:10.3109/19390211.2011.631099 · Cited by 16
Alhusseini (2010) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2010.77.83 · Cited by 15
Arslan, N., Makay, B. B., Hızlı, Ş., Koçyi̇ği̇t, A., Demircioğlu, F., Tuncel, A. S., & Çakmakçı, H. (2013) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12301 · Cited by 16
Metabolic Syndrome: Differences between Psychiatric and Internal Medicine Patients
Margari, F., Zagaria, G., Lozupone, M., Minerva, F., Pisani, R., Palasciano, G., Pastore, A., Palmieri, V. O., & Todarello, O. (2013) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.45.3.a · Cited by 17
Blüher, S., Petroff, D., Keller, A., Wagner, A., Claßen, J., & Baum, P. (2014) · Journal of Child Neurology · doi:10.1177/0883073814555190 · Cited by 16
Insulin Resistance - What is Myth and What is Reality?
Ionescu-Tirgoviste, C. (2011) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2011.123 · Cited by 16
Deng, W., Zhang, Y., Zheng, Y., Jiang, Y., Wu, Q., Liang, Z., Yang, G., & Chen, B. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-72 · Cited by 16
Effect of Pregnancy for Females Born Small on Later Life Metabolic Disease Risk
Tran, M., Gallo, L. A., Wadley, G. D., Jefferies, A. J., Moritz, K. M., & Wlodek, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045188 · Cited by 16
Chantler, S., Dickie, K., Micklesfield, L. K., & Goedecke, J. H. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0021 · Cited by 16
Schiaffini, R., Liccardo, D., Alisi, A., Benevento, D., Cappa, M., Cianfarani, S., & Nobili, V. (2015) · Hormone Research in Paediatrics · doi:10.1159/000441842 · Cited by 16
Scopinaro, N., Camerini, G. B., Papadia, F. S., Andraghetti, G., Cordera, R., & Adami, G. F. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.12.011 · Cited by 16
Exploring the Link between the Components of Metabolic Syndrome and the Risk of Depression
Liaw, F., Kao, T., Hsueh, J.-T., Chan, Y.-H., Chang, Y., & Chen, W. (2015) · BioMed Research International · doi:10.1155/2015/586251 · Cited by 17
Cheng, H. S., Yaw, H. P., Ton, S. H., Choy, S. M., Kong, J. M. X. F., & Kadir, K. A. (2016) · Nutrition · doi:10.1016/j.nut.2016.02.002 · Cited by 15
Chang, H.-P., Yao, H., & Chiang, M. (2012) · Journal of Food and Drug Analysis · doi:10.6227/jfda.2012200313 · Cited by 16
Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties
Kutoh, E., Kaneoka, N., & Hirate, M. (2014) · Endocrine Research · doi:10.3109/07435800.2014.952743 · Cited by 17
Linssen, P. B. C., Henry, R. M. A., Schalkwijk, C. G., Dekker, J. M., Nijpels, G., Rocca, H. B., & Stehouwer, C. D. A. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116640680 · Cited by 16
Sun, X., Sun, H., Zhang, J., & Ji, X. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.755 · Cited by 15
Holzberg, J. R., Jin, R., Le, N., Ziegler, T. R., Brunt, E. M., McClain, C. J., Konomi, J. V., Arteel, G. E., & Vos, M. B. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001096 · Cited by 16
Ku, C. R., Choe, E. Y., Hong, J. W., Kim, E. H., Park, S. H., Kim, S. H., & Lee, E. J. (2016) · Medicine · doi:10.1097/md.0000000000003808 · Cited by 16
Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans
Maurer, L., Brachs, S., Decker, A.-M., Brachs, M., Leupelt, V., von Schwartzenberg, R. J., Ernert, A., Bobbert, T., Krude, H., Spranger, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1788 · Cited by 16
Ciresi, A., Radellini, S., Guarnotta, V., & Giordano, C. S. D. S. (2016) · Endocrine · doi:10.1007/s12020-016-1076-5 · Cited by 16
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis
Ursini, F., D’Angelo, S., Russo, E., Nicolosi, K., Gallucci, A., Chiaravalloti, A., Bruno, C., Naty, S., Sarro, G. D., Olivieri, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163464 · Cited by 16
Sebastiano, K. M. D., Pinthus, J. H., Duivenvoorden, W., Patterson, L., Dubin, J. A., & Mourtzakis, M. (2016) · The Prostate · doi:10.1002/pros.23262 · Cited by 16
Dandanell, S., Skovborg, C., Præst, C. B., Kristensen, K. B., Nielsen, M. G., Lionett, S., Jørgensen, S. D., Vigelsø, A., Dela, F., & Helge, J. W. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.09.009 · Cited by 22
Ma, W., Wu, P.-L., Su, C.-H., & Yang, T. (2016) · Biological Research For Nursing · doi:10.1177/1099800416672581 · Cited by 16
Sohl, S. J., Wallston, K. A., Watkins, K., & Birdee, G. S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3094589 · Cited by 16
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
